Related references
Note: Only part of the references are listed.Pulmonary Nontuberculous Mycobacterial Disease Prevalence and Clinical Features An Emerging Public Health Disease
Kevin L. Winthrop et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems
D. Rebecca Prevots et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors
Claire Andrejak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Therapeutic Effects of Various Initial Combinations of Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex Pulmonary Disease
Naoki Hasegawa et al.
CHEST (2009)
Nontuberculous Mycobacterial Disease Prevalence and Risk Factors: A Changing Epidemiology
P. Maureen Cassidy et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France
C. Andrejak et al.
THORAX (2009)
Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection
T. Kikuchi et al.
THORAX (2009)
Pulmonary disease due to nontuberculous mycobacteria
Jeffrey Glassroth
CHEST (2008)
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
P. A. Jenkins et al.
THORAX (2008)
Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003
Theodore K. Marras et al.
THORAX (2007)
Non-tuberculous mycobacteria pulmonary infection:: Management and follow-up of 31 infected patients
Claire Andrejak et al.
JOURNAL OF INFECTION (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
Phung K. Lam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea
WJ Koh et al.
CHEST (2006)
Lung disease due to the more common - Nontuberculous mycobacteria
Stephen K. Field et al.
CHEST (2006)
Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients
R Maekura et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Mycobacterium avium complex pulmonary disease in patients without HIV infection
SK Field et al.
CHEST (2004)
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
SK Field et al.
CHEST (2003)
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease
Y Kobashi et al.
INTERNAL MEDICINE (2003)
Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease
TR Aksamit
CLINICS IN CHEST MEDICINE (2002)
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2000)